CT-95

· Context Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CT-95, covering 2025-07-31 to 2025-07-31. Get the full timeline:

Most recent: Clinical Trial Update: CT-95 in Advanced Cancers Associated With Mesothelin Expression [Phase 1]